Detalhe da pesquisa
1.
Phase 1b Trial Evaluating Tolerability and Activity of Targeted Fibroblast Growth Factor Receptor Inhibition in Localized Upper Tract Urothelial Carcinoma.
J Urol
; : 101097JU0000000000003928, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38573872
2.
A Phase l Study of a Tumor-targeted Systemic Nanodelivery System, SGT-94, in Genitourinary Cancers.
Mol Ther
; 24(8): 1484-91, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27480598